FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
KYTO BIOPHARMA INC [ KBPH ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 09/14/2010 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) 09/09/2010 |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 09/02/2010(1) | 09/09/2010 | J | V | 8,431,065(1) | D | (1) | 8,983,219(1) | D(1) | |
Common Stock | 8,983,219(2)(3) | I(2)(3) | Joint Filing(2)(3) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Convertible Preferred | $0.45 | 09/02/2010 | J | V | 473,674(4) | 09/14/2010 | 09/14/2010 | Common | 473,674 | (4) | 473,674 | D(4) | |||
Convertible Preferred | $0.45 | 09/14/2010 | 09/14/2010 | Common | 473,674(2)(3) | 473,674(2)(3) | I(2)(3) | Joint Filing(2)(3) |
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
Explanation of Responses: |
1. This is to report the pledge of 8,431,065 common shares owned by Credifinance Capital Corp to a corporate lender to secure indebtedness. This is reported on advice of counsel because the pledge of shares grants dispositive power to the lender, who may dispose of shares without further consent of owner in the event of default on the underlying indebtedness |
2. This is to report the pledge of 8,431,065 common shares and 473,674 convertible preferred shares owned by Credifinance Capital Corp to a corporate lender to secure indebtedness. Georges Benarroch, President and Director of the issuer, is an officer and director of Credifinance Capital Corp and responsible for day to day operations. He disclaims beneficial ownership in securities held by Credifinance Capital Corp. |
3. Form 4 Joint Filer Information: Georges Benarroch Address 49 Ave Foch Paris 75116 Designated Filer Credifinance Capital Corp. Issuer and Ticker Symbol: Kyto BioPharma Inc. (KBPH) Date of Event Requiring Statement: September 2, 2010 Relationship of Reporting Person to Issuer: Director, Officer: President Signature /s/ Georges Benarroch |
4. This is to report the pledge of 473,674 convertible preferred shares owned by Credifinance Capital Corp to a corporate lender to secure indebtedness. This is reported on advice of counsel because the pledge of shares grants dispositive power to the lender, who may dispose of shares without further consent of owner in the event of default on the underlying indebtedness |
Remarks: |
This is an amendment to Form 4 filed on September 9, 2010. Joint Filing |
/s/Georges Benarroch | 09/14/2010 | |
/s/Georges Benarroch | 09/14/2010 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |